March 07, 2024

BioPharmGuyNews.png

Purchase Data

Promoted Listings

PHB’s dedication to quality and innovation extends beyond our industry-leading BSA. Our BGG selectively binds and blocks specific molecules, providing an ideal fit when precision and effectiveness are paramount. If your application demands a solution that surpasses the capabilities of generic binders, BGG is the answer.


  • Worldwide Availability—New Zealand and U.S. Sources
  • Superior Solubility
  • Exceptional Purity
  • Low Interference, Low Background


Learn how our BGG can help with your most sensitive assays by visiting our site.

BioPharmGuy

Someone emailed and mentioned their drug company was in the Top 22 in China.


Gee, I wonder what their exact ranking might be.


-BPG


February Funding Summary

This month we tracked $2.4B in funding at 43 private companies plus five IPOs totaling $575M. Public markets slowly creeping back to life.


Biggest Round

$254M - Freenome


Cutest Round

$1M Seed - Neurenati Therapeutics


Downloadable Excel file of this funding summary is available on our downloads page.


Companies Added & Removed

17 companies added, 94 removed this week.


Try to find another data provider who brags about removing almost 100 companies. You won't because they keep theirs full of junk to brag about having a big number.


Best New Name:

Neurenati Therapeutics


Worst New Name:

Metabolomycs


You Will Be Missed:

SQZ Biotech


You Won't Be Missed:

Divide and Conquer


Excel summary file of adds/removals available free on our downloads page.

Industry

Job Bored

Our friends over at Labiotech published a listicle of the five best job boards in biotech and put BioPharmGuy at the top.


That’s nice of them and all, but a little weird since we’re not a job board. To their credit they even say as much in the second paragraph.


The only jobs we post are a list of US-based entry level jobs we gather manually. They describe it as “rough” and yeah, no arguing there. It’s old school. 


But we can still be a pretty good job search resource, specifically for those interested in looking for openings directly on company websites. We have our old shadow database of company career pages still hanging around.


If you need a job, check it out.


Mercky Deals

The scourge that is the Merck twins again reared its ugly head as C4 Therapeutics signed a deal with German Merck after previously signing one with American Merck.


History lesson: the Mercks used to be one company. Then Germany tried to fight the world (the first time, not the second), so the US seized the American branch, and it became independent, though it kept its name.


Current commercial rights to the Merck moniker vary depending on the country.


Read all about the history here


Rapport

Rapport Therapeutics has hired their first Chief People Officer.


You’d have thought they would have had a people person in place before building Rapport. But better late than never.


Fierce Puns

The forced puns and silly headlines at Fierce Biotech the past couple years have gotten pretty old, but for some reason, we found their use of the phrase cash-tastrophe to be a diamond in the rough.


Thank Deity

Societal CDMO is being acquired by CoreRx and hopefully ridding us of one of the worst company names of all-time.


Please, please, please use CoreRx for the combined entity. PLEASE!


Aggravating

To those of us who track biotech companies, almost nothing bothers us more than a fake company launch. Last week we saw a press release about a company called PulseSight Therapeutics launching with a non-viral gene therapy platform.


As we entered the company’s details into our database, we noticed their lead drug product is called PST-809 but was formerly known as EYS809. Their secondary drug candidate also was renamed at some point.


We queried our pipelines for EYS809 and a company called Eyevensys came up along with both of the current PulseSight products.


Did the new company buy the two products from the old company? Maybe, but they didn’t say anything about Eyevensys or ever acquiring the products in their press release. 


So, we don’t know if they bought the company or only the products.


But what we do know is both companies list the same mailing address on their websites. Considering that, it’s safe to say the newly ‘launched’ company is just a renamed Eyevensys, which was founded 16 years ago.


The lengths companies go to in attempt to shed their years of failure…


Bad to Worse

Hindenberg research is a group of people who dig up dirt on publicly traded companies, publish the bad stuff and try to make money by betting on the stock dropping. 


Obviously, no company would want to be a target and Renovaro is no different. After being subjected to the Hindenberg treatment, they put out a blanket response saying everything published was false and proceeded to pick apart the legal fine print.


Yeah, maybe some of the info is not correct. Perhaps most. But all of it? Every detail?? That's a little harder to believe.


Anyways, the more interesting detail was further down the company’s response letter where they mention:


“In addition to Hindenburg’s shorter attack, we became aware yesterday that our Company was listed without our knowledge on the Berlin stock exchange. We are taking immediate legal action to file a complaint with the proper authorities.”


Hold up, some random person can just list a company on a stock exchange?


What kind of mickey mouse operation do they have over in Berlin?


Team Roast - Hairesy

Normally, the quantity of hair on your Team members’ heads is not a matter of import. But things change when the company is working on a therapy for hair loss.


In that case, filling the team with lush heads is borderline offensive. We need someone with real motivation!


If you want people to believe in your passion for the work, give them someone with skin (or hair) in the game.

Health & Science

Artist Branching Out

Here we thought he was only known for his graffiti artistry. And yet it looks like BANKSY is now unifying cell typing and tissue domain segmentation for scalable spatial omics data analysis.


Where does he find the time?


Soaring Heart

Xvivo is working on preservation technology to better ensure organs aren't wasted on the way to patients. Recently, they went full Lindbergh and flew a heart across the Atlantic Ocean from the French Antilles to Paris. The transplantation was deemed a success.


Sadly, the heart was forced to slum it and fly coach aboard Air France. The helpful picture included with the article demonstrates what a heart on a plane may look like. It seems to show it taking up two seats, which is downright rude.


Henceforth, all you non-status holders can look forward to yet another group boarding ahead of you: extracorporeal organs.

Promote Your Listing at BioPharmGuy

Check your website's analytics - BioPharmGuy was likely one of your top referrers for 2023.


Bump up those referrals even more with a Premium Listing. Read more about our Promoted Listings.

Subscribe!

If you're reading this and not a subscriber, please join our mailing list.

BioPharmGuy is a registered trademark of Wilsonian LLC, Content © 2024 Wilsonian LLC